JPRN-UMIN000029433Recruiting未知
Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancer - Neoadjuvant chemotherapy for BRCAness
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Tokyo medical university
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Patients who have been administered moderate doses of anti-cancer drugs. 2.Patients who have been undergone gastrointestinal surgery 3.Active double cancers 4.Pregnant, lactating, possible pregnancy, having oral contraceptive 5.Patients who the investigator judged unsuitable for this trial
Investigators
Similar Trials
Completed
Not Applicable
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.JPRN-UMIN000046338Sapporo Medical University24
Completed
Not Applicable
A Prospective Study of Neoadjuvant Chemotherapy with Nivolumab/Gemcitabine/Cisplatin in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderKCT0003804Samsung Medical Center48
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30
Completed
Phase 2
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancerStage III gastric cancerJPRN-UMIN000001584Department of Surgery Graduate School of Medicine, Kyoto University49
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intakeesophageal cancerJPRN-UMIN000017153Second Department of Surgery, Wakayama Medical University40